medigraphic.com
SPANISH

Atención Familiar

ISSN 1405-8871 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 3

<< Back Next >>

Aten Fam 2025; 32 (3)

Is Insulin Dangerous? Myths and Realities Every Diabetes Patient Should Know

Hernández-Rosas G, Cisneros-Cruz T, Rivero-López CA
Full text How to cite this article

Language: Spanish
References: 13
Page: 219-221
PDF size: 203.01 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(Suppl_1):S27-S49.

  2. Fundación Mexicana para la Diabetes. 10 mitos y realidades de la insulina [Internet]. [citado 2025 Mar 12]. Disponible en: https://fmdiabetes.org/10-mitos-y-realidades-de-la-diabetes/

  3. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management [Internet]. [citado 2025 Mar 12]. Disponible en: https://www.nice.org.uk/guidance/ng28

  4. National Geographic Latinoamérica. Mitos sobre la diabetes que la ciencia se ocupó de derribar [Internet]. [citado 2025 Mar 12]. Disponible en: https://www.nationalgeographicla.com/ciencia/2023/11/mitos-sobre-la-diabetes-que-la-ciencia-se-ocupo-de-derribar

  5. American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl_1):S181–S206.

  6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.

  7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853

  8. American Diabetes Association. Insulin myths and facts. Clin Diabetes. 2007;25(1):39–40.

  9. McLenon J, Rogers MA. The fear of needles: A systematic review and meta-analysis. J Adv Nurs. 2019;75(1):30–42.

  10. Kim SH, Ko SH, Yoon KH, Han E. Lifestyle changes and remission in patients with new-onset type 2 diabetes: A Nationwide Cohort Study.. J Korean Med Sci. 2025; 40(7):e24.

  11. McFarlane SI. Insulin therapy and type 2 diabetes: management of weight gain. J Clin Hypertens (Greenwich). 2009 Oct;11(10):601-607.

  12. Weiner JZ, Gopalan A, Mishra P, Lipska KJ, Huang ES, Laiteerapong N, et al. Use and discontinuation of insulin treatment among adults aged 75 to 79 years with type 2 diabetes. JAMA Intern Med. 2019;179(12):1633–1641.

  13. Wu J, Morrison F, Zhao Z, Haynes G, He X, Ali AK, et al. Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study. Clin Diabetes Endocrinol. 2021;7(1):1.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Aten Fam. 2025;32